CSF-1R inhibition alters macrophage polarization and blocks glioma progression

Pyonteck, Stephanie M, Akkari, Leila, Schuhmacher, Alberto J, Bowman, Robert L, Sevenich, Lisa, Quail, Daniela F, Olson, Oakley C, Quick, Marsha L +12 more·2013·Nature Medicine

Cited by (1,005)

Items 601–700 of 1,005

  1. Microglia Express Mu Opioid Receptor: Insights From Transcriptomics and Fluorescent Reporter Mice
    Tando Maduna, Emilie Audouard, Doulaye Dembélé, Nejma Mouzaoui, David J. Reiss, Dominique Massotte, Claire Gavériaux‐Ruff · 2019 · Frontiers in Psychiatry
  2. Differential accumulation of storage bodies with aging defines discrete subsets of microglia in the healthy brain
    Jeremy Carlos Burns, Bunny Cotleur, Dirk M. Walther, Bekim Bajrami, Stephen J. Rubino, Ru Wei, Nathalie Franchimont, Susan L. Cotman, Richard M. Ransohoff, Michaël Mingueneau · 2020 · eLife
  3. Combination immunotherapy strategies for glioblastoma
    Hok Yee Chan, John Hyunkuk Choi, Christina Jackson, Michael K. Lim · 2021 · Journal of Neuro-Oncology
  4. Necrotic reshaping of the glioma microenvironment drives disease progression
    Steven M. Markwell, James Ross, Cheryl L. Olson, Daniel Jay Brat · 2022 · Acta Neuropathologica
  5. Multispectral fluorine-19 MRI enables longitudinal and noninvasive monitoring of tumor-associated macrophages
    Davide Croci, Rui Santalla Méndez, Sebastian Temme, Klara Soukup, Nadine Fournier, Anoek Zomer, Roberto Colotti, Vladimir Wischnewski, Ulrich Flögel, Ruud B. van Heeswijk et al. · 2022 · Science Translational Medicine
  6. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance
    Birgitte Grum-Schwensen, Jörg Klingelhöfer, Mette K. Beck, Charlotte Menne Bonefeld, Petra Hamerlik, Per Guldberg, Mariam Grigorian, Eugene M. Lukanidin, Noona S. Ambartsumian · 2015 · BMC Cancer
  7. Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy
    Rikke Holmgaard, Alexandra Brachfeld, Billel Gasmi, David Randolph Jones, Marissa S. Mattar, Thompson N. Doman, Mary Y. Murphy, David Schaer, Jedd D. Wolchok, Taha Merghoub · 2016 · OncoImmunology
  8. Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma
    Alejandra Gutiérrez‐González, Mónica Martínez‐Moreno, Rafael Samaniego, Nohemí Arellano‐Sánchez, Laura Salinas-Muñoz, Miguel Relloso, Antonio Valeri, Joaquín Martínez‐López, Angel Luis Corbí, Andrés Hidalgo et al. · 2016 · Blood
  9. Leveraging the immune system to treat advanced thyroid cancers
    Jena D. French, Keith Christopher Bible, Christine Spitzweg, Bryan R. Haugen, Mabel M. Ryder · 2016 · The Lancet Diabetes & Endocrinology
  10. Tumor initiating cells induce Cxcr4-mediated infiltration of pro-tumoral macrophages into the brain
    Kelda Chia, Julie Mazzolini, Marina Mione, Dirk Sieger · 2018 · eLife
  11. Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy
    Kempthorne, Liam, Yoon, Hyejin, Madore, Charlotte, Smith, Scott, Wszolek, Zbigniew K., Rademakers, Rosa, Kim, Jungsu, Butovsky, Oleg, Dickson, Dennis W. · 2020 · Acta Neuropathologica Communications
  12. What are activated and reactive glia and what is their role in neurodegeneration?
    Bennett, Mariko L., Viaene, Angela N. · 2021 · Neurobiology of Disease
  13. Glioblastoma’s Next Top Model: Novel Culture Systems for Brain Cancer Radiotherapy Research
    Seamus P. Caragher, Anthony J. Chalmers, Natividad Gomez-Roman · 2019 · Cancers
  14. 2-substituted benzothiazoles as antiproliferative agents: Novel insights on structure-activity relationships
    Alessandra Ammazzalorso, Simone Carradori, Rosa Amoroso, Inmaculada Fernández · 2020 · European Journal of Medicinal Chemistry
  15. Targeting Tumor-Associated Macrophages to Increase the Efficacy of Immune Checkpoint Inhibitors: A Glimpse into Novel Therapeutic Approaches for Metastatic Melanoma
    Claudia Ceci, Maria Grazia Atzori, Pedro Miguel Lacal, Grazia Graziani · 2020 · Cancers
  16. Exosomes in the tumor microenvironment: Promoting cancer progression
    Ye Jin, Jianming Xing, Kejin Xu, Da Liu, Yue Zhuo · 2022 · Frontiers in Immunology
  17. Tumor-associated macrophage-related strategies for glioma immunotherapy
    Fansong Tang, Yuelong Wang, Yunhui Zeng, Anqi Xiao, Aiping Tong, Jianguo Xu · 2023 · npj Precision Oncology
  18. Prognostic significance of macrophage polarization in early stage oral squamous cell carcinomas
    Manuel Weber, Christos Iliopoulos, Patrick Möbius, Maike J. Büttner-Herold, Kerstin Amann, Jutta Ries, Raimund H. M. Preidl, Friedrich Wilhelm Neukam, Falk Wehrhan · 2015 · Oral Oncology
  19. Nanoparticle-Based Magnetic Resonance Imaging on Tumor-Associated Macrophages and Inflammation
    Natalie Julie Serkova · 2017 · Frontiers in Immunology
  20. MerTK as a therapeutic target in glioblastoma
    Jing Wu, Lauren N. Frady, Ryan E. Bash, Stephanie M. Cohen, Allison N. Schorzman, Yu-Ting Su, David M. Irvin, William C. Zamboni, Xiaodong Wang, S. Frye et al. · 2018 · Neuro-Oncology
  21. Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth
    Thomas Mathivet, Claire Bouleti, Matthias Van Woensel, Fabio Stanchi, Tina Verschuere, Li‐Kun Phng, Joost Dejaegher, Marly Balcer, Ken Matsumoto, Petya B. Georgieva et al. · 2017 · EMBO Molecular Medicine
  22. Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment
    Ya Luo, Jiqiao Yang, Jing Yu, Xiaowei Liu, Chune Yu, Jianping Hu, Hubing Shi, Xuelei Ma · 2020 · Frontiers in Oncology
  23. Pharmacological targets of metabolism in disease: Opportunities from macrophages
    Alessandra Castegna, Rosanna Gissi, Alessio Menga, Monica Montopoli, Maria Favia, Antonella Viola, Marcella Canton · 2020 · Pharmacology & Therapeutics
  24. Hypoxia coordinates the spatial landscape of myeloid cells within glioblastoma to affect survival
    Michael Haley, Leoma D. Bere, James Minshull, Sokratia Georgaka, Natalia Garcia-Martin, Gareth J. Howell, David John Coope, Federico Roncaroli, Andrew Thomas King, David C. Wedge et al. · 2024 · Science Advances
  25. TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis
    Oihana Iriondo, Yarong Liu, Grace Lee, Mostafa Elhodaky, Christian Jimenez, Lin Li, Julie E. Lang, Pin Wang, Min Yu · 2018 · Nature Communications
  26. Plant Virus-Like Particle In Situ Vaccine for Intracranial Glioma Immunotherapy
    Amber E. Kerstetter-Fogle, Sourabh Shukla, Chao Wang, Veronique Beiss, Peggy L.R. Harris, Andrew Edward Sloan, Nicole F. Steinmetz · 2019 · Cancers
  27. Deletion of neuropilin 1 from microglia or bone marrow-derived macrophages slows glioma progression
    J. Miyauchi, Michael D. Caponegro, Danling Chen, Matthew Choi, Melvin Li, S. Tsirka · 2017 · Cancer Research
  28. Current State and Future Prospects of Immunotherapy for Glioma
    Neha Kamran, Mahmoud S. Alghamri, Felipe Javier Núñez, Diana Shah, Antonela Sofía Asad, Marianela Candolfi, David B. Altshuler, Pedro Ricardo Lowenstein, Maria Graciela Castro · 2018 · Immunotherapy
  29. Tumor Cells Induce LAMP2a Expression in Tumor-Associated Macrophage for Cancer Progression
    Ruibo Wang, Yantong Liu, Li Liu, Mei Chen, Xiuxuan Wang, H. J. Yang, Yanqiu Gong, Bi‐Sen Ding, Yuquan Wei, Xiawei Wei · 2018 · EBioMedicine
  30. Insights in the immunobiology of glioblastoma
    Dimitrios Strepkos, Mariam Markouli, Αλεξία Κλώνου, Christina Piperi, Athanasios G. Papavassiliou · 2019 · Journal of Molecular Medicine
  31. The Role of Tumor-Associated Myeloid Cells in Modulating Cancer Therapy
    Christiana Michael Neophytou, Chryso Pierides, Maria Christodoulou, Paul Costeas, Theodora-Christina Kyriakou, Panagiotis Papageorgis · 2020 · Frontiers in Oncology
  32. New hints towards a precision medicine strategy for IDH wild-type glioblastoma
    K. White, Kate Connor, James Clerkin, Brona M. Murphy, Manuela Salvucci, Alice C. O’Farrell, Markus Rehm, David O’Brien, Jochen H.M. Prehn, Simone P. Niclou et al. · 2020 · Annals of Oncology
  33. Breast cancer–associated macrophages promote tumorigenesis by suppressing succinate dehydrogenase in tumor cells
    Valentí Gómez, Thomas R. Eykyn, Rami Mustapha, Fabian Flores‐Borja, Victoria H. Male, Paul R. Barber, Antonia Patsialou, Ryan J. Green, Fani Panagaki, Chun W. Li et al. · 2020 · Science Signaling
  34. Tumor-associated macrophage-derived exosomes transmitting miR-193a-5p promote the progression of renal cell carcinoma via TIMP2-dependent vasculogenic mimicry
    Qing Liu, Enyang Zhao, Bo Geng, Shan Gao, Hongyang Yu, Xinyang He, Xuedong Li, Guanglu Dong, Bosen You · 2022 · Cell Death and Disease
  35. Single-Cell Transcriptomics Revealed Subtype-Specific Tumor Immune Microenvironments in Human Glioblastomas
    Yong Xiao, Zhen Wang, Mengjie Zhao, Yanxiang Deng, Mingyu Yang, Graham Su, Kun Yang, Chunfa Qian, Xinhua Hu, Yong Liu et al. · 2022 · Frontiers in Immunology
  36. Immunotherapy of glioblastoma explants induces interferon-γ responses and spatial immune cell rearrangements in tumor center, but not periphery
    Tala Shekarian, Carl Zinner, Ewelina Magdalena Bartoszek, Wandrille Duchemin, Anna T. Wachnowicz, Sabrina A. Hogan, Manina Maja Etter, Julia Flammer, Chiara Paganetti, Tomás A. Martins et al. · 2022 · Science Advances
  37. Engineered tumor cell-derived vaccines against cancer: The art of combating poison with poison
    Xinyi Zhang, Hengqing Cui, Wenjun Zhang, Zhaoshen Li, Jie Gao · 2022 · Bioactive Materials
  38. Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response
    Laura Lorenzo-Sanz, Purificacı́on Muñoz · 2019 · Cancer Microenvironment
  39. Prediction of anti-cancer nanotherapy efficacy by imaging
    Miller, Miles A., Arlauckas, Sean, Weissleder, Ralph · 2017 · Nanotheranostics
  40. Allies or Enemies—The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment
    Lisa Haas, Anna C. Obenauf · 2019 · Frontiers in Immunology
  41. Dioscin elicits anti‐tumour immunity by inhibiting macrophage M2 polarization via JNK and STAT3 pathways in lung cancer
    Luyun Cui, Guangdie Yang, Jiani Ye, Yinan Yao, Guohua Lu, Junjun Chen, Liangjie Fang, Shan Lu, Jianying Zhou · 2020 · Journal of Cellular and Molecular Medicine
  42. Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment
    Somaiyeh Malekghasemi, Jafar Majidi, Amir Baghbanzadeh, Jalal Abdolalizadeh, Behzad Baradaran, Leili Aghebati Maleki · 2020 · Advanced Pharmaceutical Bulletin
  43. Tumor-Associated Macrophages in Bladder Cancer: Biological Role, Impact on Therapeutic Response and Perspectives for Immunotherapy
    M. Leblond, Hana Zdimerova, E. Desponds, G. Verdeil · 2021 · Cancers
  44. Targeting Tumor-Associated Macrophages in Cancer Immunotherapy
    Amy J. Petty, Dwight Hall Owen, Yiping Yang, Xiaopei Huang · 2021 · Cancers
  45. One microenvironment does not fit all: heterogeneity beyond cancer cells
    Ik Sun Kim, Xiang H.-F. Zhang · 2016 · Cancer and Metastasis Reviews
  46. Inflammatory landscape of human brain tumors reveals an NFκB dependent cytokine pathway associated with mesenchymal glioblastoma
    Alfeu Zanotto‐Filho, Rosângela Mayer Gonçalves, Karina Klafke, Priscila Oliveira de Souza, Fabiane Cristine Dillenburg, Luigi Carro, Daniel Pens Gelain, José Cláudio Fonseca Moreira · 2016 · Cancer Letters
  47. Colony-stimulating factor-1-induced AIF1 expression in tumor-associated macrophages enhances the progression of hepatocellular carcinoma
    Hao Cai, Xiao‐Dong Zhu, Jian‐Yang Ao, Bo‐Gen Ye, Yuan-Yuan Zhang, Zong‐Tao Chai, Cheng-Hao Wang, Wen-Kai Shi, Man-Qing Cao, Xiao‐Long Li et al. · 2017 · OncoImmunology
  48. Solid Tumor Immunotherapy with T Cell Engager‐Armed Oncolytic Viruses
    Eleanor M. Scott, Margaret R. Duffy, Joshua D. Freedman, Kerry D. Fisher, Leonard William Seymour · 2017 · Macromolecular Bioscience
  49. Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma
    Tomás Garzón-Muvdi, Debebe Theodros, Andrew S. Luksik, Russell Maxwell, Eileen S. Kim, Christopher Mitchell Jackson, Zineb Belcaid, Sudipto Ganguly, Betty Tyler, Henry Brem et al. · 2018 · Oncotarget
  50. An active role for neurons in glioma progression: making sense of Scherer’s structures
    Shawn M. Gillespie, Michelle Monje · 2018 · Neuro-Oncology
  51. “Re-educating” Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma
    Kevin X. Liu, Shweta Joshi · 2020 · Frontiers in Immunology
  52. Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications
    Andrea Comba, Syed Mohd Faisal, Maria Luisa Varela, Todd Charles Hollon, Wajd N. Al‐Holou, Yoshie Umemura, Felipe Javier Núñez, Sébastien Motsch, Maria Graciela Castro, Pedro Ricardo Lowenstein · 2021 · Frontiers in Oncology
  53. Tumor-Associated Macrophages as Major Immunosuppressive Cells in the Tumor Microenvironment
    Anghesom Ghebremedhin, Dipti Athavale, Yan-ting Yann Zhang, Xiaodan Yao, Curt Balch, Shumei Song · 2024 · Cancers
  54. Human pontine glioma cells can induce murine tumors
    Viola Caretti, A. Charlotte P. Sewing, Tonny Lagerweij, Pepijn Schellen, Marianna Bugiani, Marc H.A. Jansen, Dannis Gilbert van Vuurden, Anna Catharina Navis, Ilona Horsman, William Peter Vandertop et al. · 2014 · Acta Neuropathologica
  55. Macrophage Susceptibility to Emactuzumab (RG7155) Treatment
    Leon Paul Pradel, Chia-Huey Ooi, Solange Romagnoli, Michael A. Cannarile, Hadassah Sade, Dominik Rüttinger, Carola Hermine Ries · 2016 · Molecular Cancer Therapeutics
  56. Promotion of Tumor Invasion by Tumor-Associated Macrophages: The Role of CSF-1-Activated Phosphatidylinositol 3 Kinase and Src Family Kinase Motility Signaling
    Amy R. Dwyer, Eloise L. Greenland, Fiona J. Pixley · 2017 · Cancers
  57. Small-molecule studies identify CDK8 as a regulator of IL-10 in myeloid cells
    Liv H Johannessen, Thomas B. Sundberg, Daniel J O'Connell, Raivo Kolde, James Berstler, Katelyn Billings, Bernard Khor, Brinton A. Seashore-Ludlow, Anne Fassl, Caitlin N. Russell et al. · 2017 · Nature Chemical Biology
  58. Latest Advances in Targeting the Tumor Microenvironment for Tumor Suppression
    Chloé Laplagne, Marcin Domagala, Augustin Le Naour, Christophe Quémerais, Dimitri Hamel, Jean‐Jacques Fournié, Bettina C. Couderc, Corinne Bousquet, Audrey Ferrand, Mary Poupot · 2019 · International Journal of Molecular Sciences
  59. The Role of Metabolic Plasticity of Tumor-Associated Macrophages in Shaping the Tumor Microenvironment Immunity
    Md Nabiul Hasan, Okan Capuk, Shivani M. Patel, Dandan Sun · 2022 · Cancers
  60. Monocyte-neutrophil entanglement in glioblastoma
    Dinorah Friedmann‐Morvinski, Dolores Hambardzumyan · 2023 · Journal of Clinical Investigation
  61. Cell membrane-based biomimetic vehicles for effective central nervous system target delivery: Insights and challenges
    Honghui Wu, Tianyuan Zhang, Ni Li, Jianqing Gao · 2023 · Journal of Controlled Release
  62. Exosome derived from tumor-associated macrophages: biogenesis, functions, and therapeutic implications in human cancers
    Manli Zhou, Xiaoyun He, Cheng Mei, Chunlin Ou · 2023 · Biomarker Research
  63. Interleukin-6/STAT3 pathway signaling drives an inflammatory phenotype in Group A ependymoma
    A. Griesinger, R. Josephson, A. Donson, J. M. Mulcahy Levy, V. Amani, D. Birks, L. Hoffman, Steffanie L Furtek, Phillip Reigan, M. Handler et al. · 2015 · Cancer immunology research
  64. The Importance of Tumor Stem Cells in Glioblastoma Resistance to Therapy
    Vincenzo Mattei, Francesca Santilli, Stefano Martellucci, Simona Delle Monache, Jessica Fabrizi, Alessandro Colapietro, Adriano Angelucci, Claudio Festuccia · 2021 · International Journal of Molecular Sciences
  65. Tumor-Mediated Neutrophil Polarization and Therapeutic Implications
    Sofia Raftopoulou, Paulina Valadez-Cosmes, Zala Nikita Mihalič, Rudolf Schicho, Julia Kargl · 2022 · International Journal of Molecular Sciences
  66. Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment
    Nikhil Pandey, Pavlos Anastasiadis, Christine P. Carney, Pranjali P. Kanvinde, Graeme F. Woodworth, Jeffrey A. Winkles, Anthony J. Kim · 2022 · Advanced Drug Delivery Reviews
  67. Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth
    Aida Rashidi, Leah K. Billingham, Andrew J Zolp, Tzu-Yi Chia, Caylee Silvers, Joshua L. Katz, Cheol H. Park, Suzi Delay, Lauren K. Boland, Yuheng Geng et al. · 2023 · Cell Metabolism
  68. Macrophages and fibroblasts as regulators of the immune response in pancreatic cancer
    Mojdeh Shakiba, David Arthur Tuveson · 2025 · Nature Immunology
  69. Pediatric gliomas as neurodevelopmental disorders
    Suzanne J. Baker, David W. Ellison, David H. Gutmann · 2015 · Glia
  70. Interactions between colon cancer cells and tumor-infiltrated macrophages depending on cancer cell-derived colony stimulating factor 1
    Huayang Wang, Qianqian Shao, Jintang Sun, Chao Ma, Wenjuan Gao, Qingjie Wang, Lei Zhao, Xun Qu · 2016 · OncoImmunology
  71. Glioblastoma: To Target the Tumor Cell or the Microenvironment?
    Steven De Vleeschouwer, Gabriele Bergers · 2017 · Codon Publications eBooks
  72. Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?
    Vildan Bozok Çetintaş, Nizar N. Batada · 2020 · Journal of Translational Medicine
  73. Viral infection of cells within the tumor microenvironment mediates antitumor immunotherapy via selective TBK1-IRF3 signaling
    Michael C. Brown, Mubeen Mosaheb, Malte Mohme, Zachary P. McKay, Eda K. Holl, Jonathan P. Kastan, Yuanfan Yang, Georgia Marie Beasley, Esther Hwang, David M. Ashley et al. · 2021 · Nature Communications
  74. Tissue-Resident and Recruited Macrophages in Primary Tumor and Metastatic Microenvironments: Potential Targets in Cancer Therapy
    Tiziana Cotechini, Aline Atallah, Arielle Grossman · 2021 · Cells
  75. The Repertoire of Small-Molecule PET Probes for Neuroinflammation Imaging: Challenges and Opportunities beyond TSPO
    Zhen Chen, Ahmed Haider, Jiahui Chen, Zhiwei Xiao, Luca B. Gobbi, Michael Honer, Uwe Grether, Steven Edward Arnold, Lee Josephson, Steven H. Liang · 2021 · Journal of Medicinal Chemistry
  76. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment
    Lunxu Li, Yu Tian · 2023 · Biomedicine & Pharmacotherapy
  77. Therapeutic Targets in Glioblastoma: Molecular Pathways, Emerging Strategies, and Future Directions
    Justin Tang, Nishika Karbhari, Jian Li Campian · 2025 · Cells
  78. Glioblastoma multiforme: novel therapeutic targets
    Matthew T. Muir, Sricharan Gopakumar, Jeffrey Isaac Traylor, Sungho Lee, Ganesh Rao · 2020 · Expert Opinion on Therapeutic Targets
  79. Myeloid signature reveals immune contexture and predicts the prognosis of hepatocellular carcinoma
    Chong Wu, Jie Lin, Yulan Weng, Dan-Ni Zeng, Jing Xu, Shufeng Luo, Li Xu, Mingyu Liu, Qiaomin Hua, Chaoqun Liu et al. · 2020 · Journal of Clinical Investigation
  80. Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches
    Eilam Yeini, Paula Ofek, Nitzan Albeck, Daniel Rodriguez Ajamil, Lena Neufeld, Anat Eldar‐Boock, Ron Kleiner, Daniella Vaskovich‐Koubi, Shani Koshrovski‐Michael, Sahar Israeli Dangoor et al. · 2020 · Advanced Therapeutics
  81. Macrophage reprogramming for therapy
    Valentina M T Bart, Robert J. Pickering, Philip R. Taylor, Natacha Ipseiz · 2020 · Immunology
  82. Decipher the Glioblastoma Microenvironment: The First Milestone for New Groundbreaking Therapeutic Strategies
    Giuseppe Nicolò Fanelli, Dario Grassini, Valerio Ortenzi, Francesco Pasqualetti, Nicola Montemurro, Paolo Perrini, Antonio Giuseppe Naccarato, Cristian Scatena · 2021 · Genes
  83. Chemotherapy Induces Tumor-Associated Macrophages that Aid Adaptive Immune Responses in Ovarian Cancer
    Owen Mortimer Heath, Chiara Berlato, Eleni Maniati, Anissa Lakhani, Colin Pegrum, Panoraia Kotantaki, Samar Elorbany, Steffen Böhm, Simon T. Barry, Alessandro Annibaldi et al. · 2021 · Cancer Immunology Research
  84. Bone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks
    Bhagelu R. Achyut, Adarsh Shankar, Asm Iskander, Roxan Ara, Kartik Angara, Peng Zeng, Robert A. Knight, Alfonso Guillermo Scicli, Ali S. Arbab · 2015 · Cancer Letters
  85. KCa3.1 inhibition switches the phenotype of glioma-infiltrating microglia/macrophages
    Alfonso Grimaldi, Giuseppina D’Alessandro, Maria Teresa Golia, Eva Melanie Grössinger, Silvia Di Angelantonio, Davide Ragozzino, Antonio Santoro, Vincenzo Esposito, Heike Wulff, Myriam Catalano et al. · 2016 · Cell Death and Disease
  86. Cancer-Associated Myeloid Regulatory Cells
    Yannick De Vlaeminck, Anna Arely González-Rascón, Cleo Goyvaerts, Karine Breckpot · 2016 · Frontiers in Immunology
  87. Genetically Engineered Macrophages: A Potential Platform for Cancer Immunotherapy
    Kara White Moyes, Nicole A. P. Lieberman, Shannon A. Kreuser, Harrison K Chinn, Conrad Winter, Gail H. Deutsch, Virginia J. Hoglund, Reid Watson, Courtney A. Crane · 2016 · Human Gene Therapy
  88. Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment
    Wenjie Yang, Shikun Yang, Feng Zhang, Feng Cheng, Xuehao Wang, Jianhua Rao · 2020 · Annals of Translational Medicine
  89. Distinction of Microglia and Macrophages in Glioblastoma: Close Relatives, Different Tasks?
    Susan Brandenburg, Anne Blank, Alexander D. Bungert, Peter Vajkoczy · 2020 · International Journal of Molecular Sciences
  90. The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma
    Juan García Valero, Alba Matas‐Céspedes, Fabián Arenas, Vanina Rodríguez, Joaquim Carreras, Neus Serrat, Martina Guerrero‐Hernández, Anella Yahiaoui, Olga Balagué, Silvia Martín et al. · 2021 · Leukemia
  91. CD169+ lymph node macrophages have protective functions in mouse breast cancer metastasis
    Carlotta Tacconi, Catharina D. Commerford, Lothar C. Dieterich, Simon Schwager, Yuliang He, Kristian Ikenberg, Ekaterina Friebel, Burkhard Becher, Sònia Tugues, Michael J. Detmar · 2021 · Cell Reports
  92. Pan-cancer analysis reveals molecular patterns associated with age
    Yajas Shah, Akanksha Verma, Andrew R. Marderstein, Jessica B. White, Bhavneet Bhinder, J. Sebastian Garcia Medina, Olivier Elemento · 2021 · Cell Reports
  93. Examining the function of macrophage oxidative stress response and immune system in glioblastoma multiforme through analysis of single-cell transcriptomics
    Xing Jin, Huabao Cai, Zhiheng Lin, Liang Zhao, Hao Ying Xu, Yanbing Song, Zhihan Wang, Chaobo Liu, Guangdong Hu, Jiajie Zheng et al. · 2024 · Frontiers in Immunology
  94. Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages
    Chayanon Ngambenjawong, Maryelise Cieslewicz, Joan G. Schellinger, Suzie Hwang Pun · 2016 · Journal of Controlled Release
  95. Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages
    Liang Pang, Yihua Pei, Gözde Uzunallı, Hyesun Hyun, L. Tiffany Lyle, Yoon Yeo · 2019 · Pharmaceutical Research
  96. The orthotopic xenotransplant of human glioblastoma successfully recapitulates glioblastoma-microenvironment interactions in a non-immunosuppressed mouse model
    Celina Garcia, Luiz Gustavo Dubois, Anna L. R. Xavier, Luiz Henrique Geraldo, Anna Carolina Carvalho da Fonseca, Ana Helena Correia, Fernanda Meirelles, Grasiella M. Ventura, Luciana Ferreira Romão, Nathalie Henriques Silva Canêdo et al. · 2014 · BMC Cancer
  97. Pathogenetic Features and Current Management of Glioblastoma
    Hong-My Nguyen, Kirsten Guz-Montgomery, Devin B. Lowe, Dipongkor Saha · 2021 · Cancers
  98. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications
    Ding-Kang Wang, Qian Zuo, Qing‐Yu He, Bin Li · 2021 · Frontiers in Immunology
  99. Recent progress of autophagy signaling in tumor microenvironment and its targeting for possible cancer therapeutics
    Subhadip Mukhopadhyay, Kewal Kumar Mahapatra, Prakash Priyadarshi Praharaj, Shankargouda Patil, Sujit K. Bhutia · 2021 · Seminars in Cancer Biology
  100. IL-34 Inhibits Acute Rejection of Rat Liver Transplantation by Inducing Kupffer Cell M2 Polarization
    Zhengfei Zhao, Guangrui Pan, Chengyong Tang, Zhongtang Li, Daofeng Zheng, Xufu Wei, Zhongjun Wu · 2018 · Transplantation